Beximco Pharmaceuticals (BXP) Stock Chart & Stock Price History → 348 million Americans lives to END as we know it? (From The Oxford Club) (Ad) Free BXP Stock Alerts GBX 40.80 +0.30 (+0.74%) (As of 04:15 AM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsStock AnalysisChartCompetitors Beximco Pharmaceuticals Stock Price Performance5 Day Performance+4.62%1 Month Performance+11.78%3 Month Performance+2.00%6 Month Performance-5.99%Year-To-Date Performance-1.69%1 Year Performance+7.37% Receive BXP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Huge AlertsWhy Is Gold On a MASSIVE rally? Gold has been on a tear this year. The yellow metal has hit an all-time high of $2,4231.29 recently and the rally could be far from over. From central banks to even Costco customers, it seems everyone is buying gold these days. With Wall Street watching the gold space carefully, now is a perfect time to pay attention to this stock.This Little known Company is a uniquely structured for profit BXP Stock Chart for Friday, May, 17, 2024 BXP Chart by TradingView Beximco Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/16/2024GBX 39.11GBX 40.80+4.32%GBX 40.80GBX 40.806,040 shs£182.01 million05/15/2024GBX 40.92GBX 39.11-4.42%GBX 39.11GBX 39.11594 shs£174.47 million05/14/2024GBX 41GBX 40.92-0.20%GBX 42GBX 39.1142,609 shs£182.55 million05/13/2024GBX 39GBX 41+5.13%GBX 42GBX 39227,094 shs£182.91 million05/10/2024GBX 38.20GBX 39.96+4.61%GBX 39.96GBX 38189,997 shs£178.27 million05/09/2024GBX 37.50GBX 38.20+1.87%GBX 38.20GBX 36.3021,498 shs£170.41 million Get the Latest News and Ratings for BXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/08/2024GBX 37.50GBX 37.50GBX 38.17GBX 3730,000 shs£167.29 million05/07/2024GBX 38GBX 37.50-1.32%GBX 38GBX 36.2532,555 shs£167.29 million05/06/2024GBX 37.50GBX 38+1.33%GBX 38GBX 38301,080 shs£169.52 million05/03/2024GBX 36.50GBX 38+4.11%GBX 38GBX 38301,080 shs£169.52 million05/02/2024GBX 37GBX 36.50-1.35%GBX 37GBX 36.5011,412 shs£162.83 million05/01/2024GBX 36.50GBX 37+1.37%GBX 37GBX 37206,414 shs£165.06 million04/30/2024GBX 36.50GBX 36.50GBX 38.45GBX 36.50204,261 shs£162.83 million04/29/2024GBX 36.50GBX 36.50GBX 36.50GBX 36105,000 shs£162.83 million04/26/2024GBX 36.50GBX 36.50GBX 36.50GBX 36255,000 shs£162.83 million04/25/2024GBX 36.50GBX 36.50GBX 36.50GBX 36.475,473 shs£162.83 million04/24/2024GBX 36.50GBX 36.50GBX 36.55GBX 36.5010,477 shs£162.83 million04/23/2024GBX 36.08GBX 36.50+1.18%GBX 38GBX 36.5023,201 shs£162.83 million04/22/2024GBX 37GBX 36.08-2.50%GBX 36.08GBX 36111,428 shs£160.93 million04/19/2024GBX 36.60GBX 37+1.09%GBX 37GBX 3624,443 shs£165.06 million04/18/2024GBX 36.50GBX 36.60+0.27%GBX 36.60GBX 36.4034,232 shs£163.28 million04/17/2024GBX 36.40GBX 36.50+0.27%GBX 36.50GBX 36.4019,000 shs£162.83 million04/16/2024GBX 36.47GBX 36.40-0.19%GBX 36.40GBX 36.4019,000 shs£162.38 million04/15/2024GBX 36.50GBX 36.47-0.08%GBX 36.47GBX 36.4710,300 shs£162.70 million04/12/2024GBX 36.50GBX 36.50GBX 36.95GBX 35.25121,696 shs£162.83 million04/11/2024GBX 36.22GBX 36.50+0.77%GBX 37GBX 36.50150,000 shs£162.83 million04/10/2024GBX 36.50GBX 36.22-0.77%GBX 37.25GBX 36.2233,674 shs£161.58 million04/09/2024GBX 37.40GBX 36.50-2.41%GBX 37.42GBX 36.1618,535 shs£162.83 million04/08/2024GBX 36.50GBX 37.40+2.47%GBX 37.50GBX 37.4043,773 shs£166.85 million04/05/2024GBX 37.50GBX 38+1.33%GBX 38GBX 35.7512,800 shs£169.52 million04/04/2024GBX 38.25GBX 37.50-1.95%GBX 38.40GBX 3534,746 shs£167.29 million04/03/2024GBX 37GBX 38.25+3.36%GBX 38.40GBX 3534,746 shs£170.62 million04/02/2024GBX 39GBX 37-5.13%GBX 40GBX 3723,586 shs£165.06 million04/01/2024GBX 39GBX 39GBX 39GBX 38.225,317 shs£173.98 million03/29/2024GBX 39GBX 39GBX 39GBX 38.225,317 shs£173.98 million03/28/2024GBX 39GBX 39GBX 39GBX 38.225,319 shs£173.98 million03/27/2024GBX 39.50GBX 39-1.27%GBX 39.40GBX 3951,715 shs£173.98 million03/26/2024GBX 39.50GBX 39.50GBX 39.50GBX 39.5010,000 shs£176.21 million03/25/2024GBX 38.50GBX 39.50+2.60%GBX 39.50GBX 3830,000 shs£176.21 million03/22/2024GBX 38.50GBX 38.50GBX 38.50GBX 38.5050,000 shs£171.75 millionDoes this make you sick? (Ad)The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit03/21/2024GBX 38.50GBX 38.50GBX 38.75GBX 38.505,151 shs£171.75 million03/20/2024GBX 38.50GBX 38.50GBX 38.75GBX 38.505,151 shs£171.75 million03/19/2024GBX 37.25GBX 38.50+3.36%GBX 38.75GBX 38.505,151 shs£171.75 million03/18/2024GBX 38.50GBX 37.25-3.25%GBX 39GBX 37.2533,310 shs£166.18 million03/15/2024GBX 37.50GBX 38.50+2.67%GBX 40GBX 37.7532,824 shs£171.75 million03/14/2024GBX 39GBX 37.50-3.85%GBX 40GBX 37.50228,908 shs£167.29 million03/13/2024GBX 38.20GBX 39+2.09%GBX 40.10GBX 3883,640 shs£173.98 million03/12/2024GBX 40GBX 38.20-4.50%GBX 40.30GBX 38.2034,768 shs£170.41 million03/11/2024GBX 40.50GBX 40-1.23%GBX 41GBX 4050,000 shs£178.44 million03/08/2024GBX 40.50GBX 40.50GBX 40.50GBX 39214,000 shs£180.68 million03/07/2024GBX 39.16GBX 40.50+3.43%GBX 40.50GBX 39.164,772 shs£180.68 million03/06/2024GBX 39.65GBX 39.16-1.25%GBX 39.16GBX 39.165,131 shs£174.68 million03/05/2024GBX 39.65GBX 39.65GBX 40.50GBX 39.658,697 shs£176.88 million03/04/2024GBX 40.50GBX 39.65-2.10%GBX 39.65GBX 39.658,697 shs£176.88 million03/01/2024GBX 40.50GBX 40.35-0.37%GBX 42GBX 39.5715,001 shs£180.01 million02/29/2024GBX 40.50GBX 40.50GBX 40.50GBX 39.5717,516 shs£180.68 million02/28/2024GBX 40.50GBX 40.50GBX 40.50GBX 39.7014,345 shs£180.68 million02/27/2024GBX 40.50GBX 40.50GBX 40.50GBX 39.7027,575 shs£180.68 million02/26/2024GBX 40.50GBX 40.50GBX 40.50GBX 39.7027,575 shs£180.68 million02/23/2024GBX 40.50GBX 40-1.23%GBX 40.75GBX 39.2555,056 shs£178.44 million02/22/2024GBX 41GBX 40.50-1.22%GBX 41.45GBX 40.5018,370 shs£180.68 million02/21/2024GBX 40GBX 41+2.50%GBX 41GBX 40.3010,000 shs£182.91 million02/20/2024GBX 39.56GBX 40+1.13%GBX 40.32GBX 4040,930 shs£178.44 million02/19/2024GBX 40GBX 39.56-1.11%GBX 41GBX 39.5621,500 shs£176.46 million02/16/2024GBX 40.45GBX 40.34-0.28%GBX 40.34GBX 40.3410,000 shs£179.95 million Related Companies: Alliance Pharma Stock Chart Allergy Therapeutics Stock Chart Animalcare Group Stock Chart ECO Animal Health Group Stock Chart Celadon Pharmaceuticals Stock Chart Venture Life Group Stock Chart Benchmark Stock Chart Avacta Group Stock Chart Arix Bioscience Stock Chart hVIVO Stock Chart Receive BXP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (LON:BXP) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldWhy Is Gold On a MASSIVE rally? Huge AlertsUrgent Alert: Is the U.S. Implementing a Digital Dollar?Gold Gate Capital348 million Americans lives to END as we know it?The Oxford ClubBiden Nomination CANCELED?The Freeport SocietyGold Set to EXPLODE!Gold Safe ExchangeDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beximco Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.